Загрузка...
Clarithromycin overcomes resistance to lenalidomide and dexamethasone in multiple myeloma
The combination of clarithromycin, lenalidomide and dexamethasone (BiRd) has led to highly durable responses in newly diagnosed myeloma. However, the ability of clarithromycin to overcome resistance to lenalidomide and dexamethasone (Rd) is not known. To study this, we performed a retrospective anal...
Сохранить в:
| Опубликовано в: : | Am J Hematol |
|---|---|
| Главные авторы: | , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
2014
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4390045/ https://ncbi.nlm.nih.gov/pubmed/24723438 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ajh.23733 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|